About Psoriasis > Treating Psoriasis

Biologic Drugs: Fact Sheets

Download the enbrel fact sheetEnbrel (etanercept)

  • FDA-approved for treating psoriasis, psoriatic arthritis, rheumatoid arthritis, juvenile rheumatoid arthritis and ankylosing spondylitis
  • Patients give themselves an injection once or twice a week
  • Taken continuously to maintain results
  • May reduce the progression of joint damage
  • Occasional blood tests are recommended
Download the humira fact sheet

Humira (adalimumab)

  • FDA-approved for treating psoriasis, psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis
  • Individuals give themselves an injection usually every other week
  • Patients should be screened for latent (hidden) tuberculosis (TB) before taking Humira
  • May reduce the progression of joint damage
  • Occasional blood tests are recommended

      If you take Humira and recently received a letter from United Healthcare indicating they will no longer
      provide coverage, call 1.800.4.HUMIRA (448.6472) to discuss how to obtain or continue co-pay
      assistance. Learn

Download the remicade fact sheet

Remicade (infliximab)

  • FDA-approved for psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, ankylosing spondylitis and Crohn’s disease
  • Given by three infusions in a doctor’s office during the first six weeks of treatment
  • Later infusions repeated every eight weeks
  • Patients should be screened for latent (hidden) tuberculosis (TB) before taking infliximab
  • May reduce the progression of joint damage
  • Blood tests are recommended on a regular basis

Simponi (golimumab)

Download the simponi fact sheet
  • FDA-approved for psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis
  • Patients give themselves an injection one time per month
  • Patients should be screened for latent (hidden) tuberculosis (TB) before taking
  • May reduce the progression of joint damage
  • Blood tests are recommended on a regular basis

Stelara (ustekinumab)

Download the stelara fact sheet
  • FDA-approved for plaque psoriasis and psoriatic arthritis
  • After two initial doses at weeks 0 and 4, patients receive an injection by a health care provider once every 12 weeks
  • Patients should be screened for latent (hidden) tuberculosis (TB) before taking Stelara
  • Occasional blood tests are recommended